MACC1 and esophageal squamous cell carcinoma: Furthermore, MACC1 knockdown impedes ESCC cell autophagy, and concurrent treatment with 3-methyladenine, an autophagy inhibitor, mitigates the MACC1-induced malignant phenotype in ESCC cells.